{
 "@context": "https://clearank.com/llms.txt",
 "@type": "clearank:AssetAnalysis",
 "url": "https://clearank.com/stock/cme-stock-analysis/",
 "dataUrl": "https://clearank.com/stock/cme-stock-analysis/data.json",
 "title": "CME Group Inc. (CME) Stock Forecast & Price Target (2026)",
 "description": "Is CME Group (CME) a Buy or Sell today? Get the AI trade setup, key support levels and derivatives volume outlook. Updated daily.",
 "headline": "CME Group Inc. (CME)",
 "published": "2026-09-01T09:27:07+00:00",
 "modified": "2026-09-12T03:45:58.473+00:00",
 "generated": "2026-09-12T22:53:37.233Z",
 "language": "en-US",
 "publisher": {
  "name": "CleaRank",
  "url": "https://clearank.com/"
 },
 "disclaimer": "Educational and informational only; not financial advice. AI-generated analysis reviewed by the CleaRank editorial team; prices delayed up to 15 minutes.",
 "asset": {
  "ticker": "CME",
  "name": "CME Group Inc.",
  "type": "Common Stock",
  "exchange": "NASDAQ",
  "currency": "USD",
  "sector": "Financial Services",
  "industry": "Financial Data & Stock Exchanges",
  "country": "United States",
  "website": "https://www.cmegroup.com"
 },
 "quote": {
  "price": 275.54,
  "previousClose": 274.07,
  "change": 1.47,
  "changePercent": 0.54,
  "open": 275.35001,
  "high": 276.14999,
  "low": 271.29501,
  "volume": 1050560,
  "averageVolume": 1977876,
  "marketCap": 99078473722,
  "fiftyTwoWeekHigh": 329.16,
  "fiftyTwoWeekLow": 218.31,
  "marketOpen": false,
  "asOf": "2026-09-12T03:45:57.000Z"
 },
 "statistics": {
  "pe": 23.265705,
  "eps": 11.78,
  "dividendYield": 0.01887203251339173,
  "beta": 0.275,
  "priceToSales": 14.584428,
  "priceToBook": 3.7128806,
  "revenueTtm": 6757199872,
  "grossMargin": 0.86314617278162,
  "returnOnEquity": 0.15802
 },
 "technicals": {
  "rsi": 50.73,
  "macd": 3.78,
  "sma50": 262.67,
  "sma200": 278.8,
  "rsiSignal": "Neutral",
  "trend": "Bearish",
  "pricePosition": "Bullish",
  "macdSignal": "Bullish",
  "rating": "Bullish"
 },
 "analysis": {
  "rating": "Hold",
  "score": 59,
  "consensus": "Hold",
  "fairValue": 285,
  "analystTarget": 285,
  "analystCount": 16,
  "wallStreetConsensus": "Hold",
  "generatedAt": "2026-09-12T03:45:57.000Z",
  "priceAtAnalysis": 275.54001,
  "volatility": {
   "daily": 1.22,
   "risk": "standard"
  }
 },
 "tradePlan": {
  "bias": "Neutral",
  "conservativeEntry": 272.78,
  "aggressiveEntry": 275.54,
  "stopLoss": 264.6,
  "stopLossPercent": 3,
  "targets": [
   280.97,
   286.42,
   294.61
  ]
 },
 "projections": {
  "basis": "Monte Carlo simulation on historical return distribution, re-run daily; not price targets",
  "years": [
   {
    "year": 2027,
    "downside10th": 218.38,
    "base": 299,
    "upside90th": 409.4
   },
   {
    "year": 2028,
    "downside10th": 208.05,
    "base": 324.47,
    "upside90th": 506.03
   },
   {
    "year": 2029,
    "downside10th": 204.31,
    "base": 352.1,
    "upside90th": 606.8
   },
   {
    "year": 2030,
    "downside10th": 203.8,
    "base": 382.08,
    "upside90th": 716.31
   },
   {
    "year": 2031,
    "downside10th": 205.35,
    "base": 414.62,
    "upside90th": 837.17
   },
   {
    "year": 2032,
    "downside10th": 208.38,
    "base": 449.93,
    "upside90th": 971.48
   },
   {
    "year": 2033,
    "downside10th": 212.6,
    "base": 488.24,
    "upside90th": 1121.27
   },
   {
    "year": 2034,
    "downside10th": 217.83,
    "base": 529.82,
    "upside90th": 1288.65
   },
   {
    "year": 2035,
    "downside10th": 223.98,
    "base": 574.94,
    "upside90th": 1475.85
   },
   {
    "year": 2036,
    "downside10th": 230.97,
    "base": 623.9,
    "upside90th": 1685.32
   }
  ]
 },
 "faqCount": 8,
 "sources": [
  "TwelveData",
  "Wall Street consensus"
 ],
 "sections": [
  {
   "id": "price",
   "title": "CME Price Analysis"
  },
  {
   "id": "market-metrics",
   "title": "Market Metrics",
   "facts": {
    "Open": "$275.35",
    "Day Range": "$271.30 to $276.15",
    "Prev Close": "$274.07",
    "Volume": "1.05M",
    "52-Week Range": "$218.31 to $329.16",
    "Market Cap": "$99.08B"
   }
  },
  {
   "id": "peer-benchmarking",
   "title": "Peer Benchmarking",
   "text": [
    "Sector Position Analysis Trading at a significant premium to sector peers (+41%), suggesting market expectations for superior growth or market position."
   ]
  },
  {
   "id": "analysis",
   "title": "CME Analysis",
   "text": [
    "CME Group Inc. is currently trading above its 50-day Simple Moving Average of $262.67, indicating near-term positive momentum, but remains below its 200-day Simple Moving Average of $278.80, suggesting a longer-term downtrend. The Relative Strength Index (RSI) is at 50.73, which is neutral, and the MACD indicator is positive at 3.78, suggesting a balanced momentum. The nearest support level is the 50-day SMA at $262.67, while resistance is observed near the 200-day SMA at $278.80. Trading volume has been significantly below average, down 46.9%, which may indicate a lack of strong conviction from market participants. The current price action suggests a consolidation phase, with key levels to watch being the 50-day SMA for support and the 200-day SMA for resistance.",
    "Wall Street analysts project strong revenue growth for CME Group Inc., with an estimated +10.00% for the current quarter and +8.00% for the current year, which could drive positive price action.",
    "Insiders have sold a significant amount ($37.6 million) compared to purchases ($659.6 thousand), indicating a 'Moderate Sell Signal' that may weigh on investor sentiment.",
    "CME Group Inc. is currently trading below its 200-day SMA of $278.80, suggesting a potential longer-term downtrend or consolidation phase that requires monitoring.",
    "The latest earnings report showed an EPS beat of 2.75% ($2.99 actual vs $2.91 estimate), leading to a positive price reaction of 2.04%.",
    "The base case outlook for CME Group Inc. anticipates a period of consolidation around its current price, with potential for a modest upward move towards the median analyst target of $285.00, representing a 3.4% upside. Forward revenue growth estimates are positive, projecting around 10.00% for the current quarter and 8.00% for the full year, which could support the stock price if realized. However, several factors could alter this trajectory. A failure to meet forward revenue expectations or increased insider selling could pressure the stock lower, potentially testing the 50-day SMA support at $262.67. Conversely, a strong earnings beat or positive macroeconomic developments favoring exchanges could push the price towards the 200-day SMA resistance at $278.80 and beyond. The current valuation premium relative to sector peers also presents a headwind for significant upside."
   ],
   "lists": {
    "ProTips": [
     "Monitor upcoming earnings reports closely, as recent performance has shown mixed results with slight beats and misses.",
     "Pay attention to insider transaction activity; a continuation of the net selling trend could signal caution.",
     "Given the stock is trading below its 200-day SMA, consider risk management strategies such as setting stop-loss orders near the 50-day SMA support level."
    ]
   },
   "catalysts": [
    {
     "type": "Bullish",
     "title": "Positive Revenue Growth Estimates",
     "text": "Wall Street analysts project strong revenue growth for CME Group Inc., with an estimated +10.00% for the current quarter and +8.00% for the current year, which could drive positive price action.",
     "source": "Wall Street Estimates"
    },
    {
     "type": "Bearish",
     "title": "Moderate Insider Selling Signal",
     "text": "Insiders have sold a significant amount ($37.6 million) compared to purchases ($659.6 thousand), indicating a 'Moderate Sell Signal' that may weigh on investor sentiment.",
     "source": "Insider Transactions"
    },
    {
     "type": "Neutral",
     "title": "Trading Below 200-Day Moving Average",
     "text": "CME Group Inc. is currently trading below its 200-day SMA of $278.80, suggesting a potential longer-term downtrend or consolidation phase that requires monitoring.",
     "source": "Technical Analysis"
    },
    {
     "type": "Bullish",
     "title": "Recent Earnings Beat",
     "text": "The latest earnings report showed an EPS beat of 2.75% ($2.99 actual vs $2.91 estimate), leading to a positive price reaction of 2.04%.",
     "source": "Earnings Report"
    }
   ]
  },
  {
   "id": "key-statistics",
   "title": "Key Statistics",
   "text": [
    "CME Group Inc. exhibits a Price-to-Earnings (P/E) ratio of 23.27, which is notably higher than the sector median of 16.5, suggesting a premium valuation relative to its peers in the Financial Services industry. The company's earnings per share (EPS) for the trailing twelve months is $11.78. While revenue growth was a modest 0.8% year-over-year, forward estimates from Wall Street analysts project revenue growth of approximately 10.00% for the current quarter and 8.00% for the current year, indicating expected acceleration. The company's Return on Equity (ROE) is not directly provided but sector averages stand at 13.8%. The current price of $275.54 is trading below the median analyst price target of $285.00, offering a limited upside potential of 3.4%. The dividend yield is approximately 4.10%, providing a steady income stream for investors. The valuation appears stretched compared to sector averages, but forward revenue growth estimates offer some support.",
    "CME Group Inc. most recently reported an EPS of $2.99 for the quarter ending July 22, 2026, surpassing the analyst estimate of $2.91 by 2.75% and resulting in a 2.04% price increase. Prior to this, the company missed estimates slightly in the April 2026 quarter (-0.3% surprise) and beat expectations in the February 2026 quarter (1.09% surprise). Overall, recent earnings performance shows a pattern of slight beats and misses, with the latest quarter demonstrating positive momentum.",
    "A primary risk for CME Group Inc. is its valuation, with a P/E ratio of 23.27 significantly higher than the sector median of 16.5, indicating potential downside if growth expectations are not met. Moderate insider selling, with $37.6 million in sales versus $659.6 thousand in purchases, suggests a lack of strong conviction from management. Also, the stock is trading below its 200-day moving average, signaling potential longer-term weakness."
   ],
   "tables": [
    {
     "caption": "",
     "columns": [],
     "rows": [
      {
       "label": "Market Cap",
       "cells": [
        "98.99M"
       ]
      },
      {
       "label": "P/E Ratio",
       "cells": [
        "23.27"
       ]
      },
      {
       "label": "EPS (TTM)",
       "cells": [
        "11.78"
       ]
      },
      {
       "label": "Dividend Yield",
       "cells": [
        "4.10%"
       ]
      },
      {
       "label": "52 Week High",
       "cells": [
        "329.16"
       ]
      },
      {
       "label": "52 Week Low",
       "cells": [
        "218.31"
       ]
      }
     ]
    }
   ]
  },
  {
   "id": "technical-indicators",
   "title": "Technical Indicators",
   "text": [
    "Technical Rating Bullish RSI Neutral SMA Cross Bearish Price vs SMA Bullish MACD Bullish Moving averages show a lagging Death Cross (50-day: $262.67, 200-day: $278.80), price sits above the 50-day SMA but below the 200-day SMA - a mixed posture."
   ],
   "facts": {
    "RSI": "Neutral",
    "SMA Cross": "Bearish",
    "Price vs SMA": "Bullish",
    "MACD": "Bullish"
   },
   "tables": [
    {
     "caption": "",
     "columns": [],
     "rows": [
      {
       "label": "RSI (14)",
       "cells": [
        "50.73"
       ]
      },
      {
       "label": "MACD",
       "cells": [
        "3.78"
       ]
      },
      {
       "label": "SMA 50",
       "cells": [
        "262.67"
       ]
      },
      {
       "label": "SMA 200",
       "cells": [
        "278.80"
       ]
      }
     ]
    }
   ]
  },
  {
   "id": "correlations",
   "title": "Market Correlations",
   "text": [
    "How this stock moves relative to other assets",
    "Based on 1 year of daily price data. Correlations may vary over different time periods."
   ],
   "facts": {
    "Correlation with S&P 500 (SPY)": "-0.10",
    "Correlation with Nasdaq 100 (QQQ)": "-0.19",
    "Correlation with Bitcoin (BTC)": "+0.08",
    "Correlation with Gold (XAU)": "+0.01"
   }
  },
  {
   "id": "trade-plans",
   "title": "CME Trade Plans",
   "text": [
    "Specific entry, exit, and risk management levels",
    "Enter now if confident",
    "Volatility-Adjusted Stop Loss Calculated based on RSI (50.7) and current market volatility",
    "Consider scaling out: Take 50% profit at Target 1, 30% at Target 2, let 20% run to Target 3"
   ],
   "facts": {
    "TARGET 1": "$280.97",
    "TARGET 2": "$286.42",
    "TARGET 3": "$294.61",
    "STOP LOSS": "$264.60"
   }
  },
  {
   "id": "risk",
   "title": "Risk & Volatility",
   "facts": {
    "Daily Volatility": "1.22%"
   },
   "lists": {
    "Risk considerations": [
     "Monitor position sizing based on current volatility levels",
     "Consider stop-loss placement beyond recent price range",
     "Diversification helps mitigate single-stock risk exposure"
    ]
   }
  },
  {
   "id": "growth",
   "title": "Growth of $10,000",
   "text": [
    "A $10,000 investment in CME in September 2016 would be worth about $25,471 today, compared with about $35,328 for the same investment in the S&P 500 benchmark."
   ]
  },
  {
   "id": "monte-carlo",
   "title": "Monte Carlo Projection (10yr)",
   "text": [
    "CleaRank's 10-year Monte Carlo simulation projects that a $10,000 investment in CME today could grow to about $22,643 by 2036 in the base case, with a bull case near $61,164 and a bear case around $8,382. Projections are statistical simulations, not guarantees."
   ]
  },
  {
   "id": "price-prediction",
   "title": "CME Stock Price Prediction: 2030",
   "text": [
    "CleaRank's simulation projects a price near $382 for CME by 2030 in the base case, from $276 today (1.4x over 4 years). The downside path ends near $204. These are outcomes of a Monte Carlo simulation run on CME's historical return distribution, not price targets, and they assume no dividends are reinvested.",
    "Method: 10,000 simulated price paths using CME's historical volatility and drift, re-run daily. The base case is the median path; the two outer columns are the 10th and 90th percentile outcomes, which widen with time because uncertainty compounds. Simulations are not guarantees, and past volatility does not predict future returns. This is analysis, not investment advice."
   ],
   "tables": [
    {
     "caption": "CME simulated price paths by year",
     "columns": [
      "Year",
      "Downside (10th pct)",
      "Base case",
      "Upside (90th pct)"
     ],
     "rows": [
      {
       "label": "2027",
       "cells": [
        "$218",
        "$299",
        "$409"
       ]
      },
      {
       "label": "2028",
       "cells": [
        "$208",
        "$324",
        "$506"
       ]
      },
      {
       "label": "2029",
       "cells": [
        "$204",
        "$352",
        "$607"
       ]
      },
      {
       "label": "2030",
       "cells": [
        "$204",
        "$382",
        "$716"
       ]
      },
      {
       "label": "2031",
       "cells": [
        "$205",
        "$415",
        "$837"
       ]
      },
      {
       "label": "2032",
       "cells": [
        "$208",
        "$450",
        "$971"
       ]
      },
      {
       "label": "2033",
       "cells": [
        "$213",
        "$488",
        "$1,121"
       ]
      },
      {
       "label": "2034",
       "cells": [
        "$218",
        "$530",
        "$1,289"
       ]
      },
      {
       "label": "2035",
       "cells": [
        "$224",
        "$575",
        "$1,476"
       ]
      },
      {
       "label": "2036",
       "cells": [
        "$231",
        "$624",
        "$1,685"
       ]
      }
     ]
    }
   ]
  },
  {
   "id": "people-also-watch",
   "title": "People Also Watch",
   "links": [
    {
     "text": "TROW T. Rowe Price Group Inc. NASDAQ $106.29 -1.17%",
     "url": "https://clearank.com/stock/t-rowe-price-trow/"
    },
    {
     "text": "ICE Intercontinental Exchange, Inc. NYSE $157.45 +1.05%",
     "url": "https://clearank.com/stock/intercontinental-exchange-ice/"
    },
    {
     "text": "MKTX MarketAxess Holdings Inc. NASDAQ $163.00 -0.06%",
     "url": "https://clearank.com/stock/mktx-stock-analysis/"
    },
    {
     "text": "WAL Western Alliance Bancorporation NYSE $79.29 +0.01%",
     "url": "https://clearank.com/stock/wal-stock-analysis/"
    },
    {
     "text": "HBAN Huntington Bancshares Incorporated NASDAQ $16.86 +0.78%",
     "url": "https://clearank.com/stock/hban-stock-analysis/"
    },
    {
     "text": "JPM JPMorgan Chase & Co. NYSE $356.23 +0.76%",
     "url": "https://clearank.com/stock/jpmorgan-chase-jpm/"
    },
    {
     "text": "C Citigroup Inc. NYSE $138.82 +0.23%",
     "url": "https://clearank.com/stock/citigroup-c/"
    },
    {
     "text": "PGR The Progressive Corporation NYSE $217.62 +0.66%",
     "url": "https://clearank.com/stock/progressive-pgr/"
    }
   ]
  },
  {
   "id": "related-comparisons",
   "title": "Popular Comparisons",
   "links": [
    {
     "text": "LLY vs ABBV Comparison Head-to-head analysis →",
     "url": "https://clearank.com/compare/lly-vs-abbv/"
    },
    {
     "text": "SCHD vs JEPI Comparison Head-to-head analysis →",
     "url": "https://clearank.com/compare/schd-vs-jepi/"
    },
    {
     "text": "XLK vs QQQ Comparison Head-to-head analysis →",
     "url": "https://clearank.com/compare/xlk-vs-qqq/"
    }
   ]
  },
  {
   "id": "insider-trading",
   "title": "CME Insider Trading Analysis",
   "facts": {
    "Bought": "$659.6K",
    "Sold": "$37.6M",
    "Insiders": "32",
    "Avg Transaction": "$1.2M"
   },
   "tables": [
    {
     "caption": "Recent insider transactions in CME",
     "columns": [
      "Date",
      "Insider",
      "Type",
      "Shares",
      "Value"
     ],
     "rows": [
      {
       "label": "May 15, 2026",
       "cells": [
        "DUFFY TERRENCE A Chief Executive Officer",
        "Sell",
        "35.0K",
        "$10.4M"
       ]
      },
      {
       "label": "Apr 29, 2024",
       "cells": [
        "DUFFY TERRENCE A Chief Executive Officer",
        "Sell",
        "40.0K",
        "$8.4M"
       ]
      },
      {
       "label": "Dec 12, 2019",
       "cells": [
        "DUFFY TERRENCE A Chief Executive Officer",
        "Sell",
        "39.3K",
        "$8.0M"
       ]
      },
      {
       "label": "Mar 11, 2025",
       "cells": [
        "DUFFY TERRENCE A Chief Executive Officer",
        "Sell",
        "30.0K",
        "$7.8M"
       ]
      },
      {
       "label": "Aug 1, 2019",
       "cells": [
        "DUFFY TERRENCE A Chief Executive Officer",
        "Sell",
        "35.0K",
        "$7.0M"
       ]
      },
      {
       "label": "Dec 11, 2025",
       "cells": [
        "DUFFY TERRENCE A Chief Executive Officer",
        "Sell",
        "25.0K",
        "$6.7M"
       ]
      },
      {
       "label": "Aug 18, 2023",
       "cells": [
        "DUFFY TERRENCE A Chief Executive Officer",
        "Sell",
        "30.0K",
        "$6.1M"
       ]
      },
      {
       "label": "May 19, 2021",
       "cells": [
        "DUFFY TERRENCE A Chief Executive Officer",
        "Sell",
        "29.0K",
        "$6.1M"
       ]
      },
      {
       "label": "Jul 28, 2023",
       "cells": [
        "CUTINHO SUNIL KIRAN Chief Technology Officer",
        "Sell",
        "19.4K",
        "$3.9M"
       ]
      },
      {
       "label": "Feb 10, 2022",
       "cells": [
        "KOMETER KEVIN D Chief Technology Officer",
        "Sell",
        "13.5K",
        "$3.3M"
       ]
      }
     ]
    }
   ],
   "links": [
    {
     "text": "SEC Form 4",
     "url": "https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&company=CME+Group+Inc.&type=4&dateb=&owner=include&count=40&search_text=&action=getcompany"
    }
   ]
  },
  {
   "id": "faq",
   "title": "Frequently Asked Questions"
  }
 ],
 "faq": [
  {
   "question": "Is CME Group Inc. stock a buy right now?",
   "answer": "CME Group Inc. is currently rated as 'Hold' by Wall Street analysts, with a consensus score of 59 out of 100. The median analyst price target is $285.00, suggesting a limited upside of 3.4% from the current price of $275.54. While recent earnings showed a slight beat, moderate insider selling and a P/E ratio above the sector average warrant caution."
  },
  {
   "question": "What is CME Group Inc.'s price target for September 2026?",
   "answer": "The median analyst price target for CME Group Inc. is $285.00, indicating a 3.4% upside from the current trading price of $275.54. This target is based on the consensus of 16 Wall Street analysts."
  },
  {
   "question": "How is CME Group Inc.'s revenue growth trending?",
   "answer": "CME Group Inc. reported a year-over-year revenue growth of 0.8%. However, forward estimates are more optimistic, with current quarter revenue growth projected at +10.00% and current year growth at +8.00%."
  },
  {
   "question": "What are the key technical levels for CME Group Inc. stock?",
   "answer": "CME Group Inc. is trading above its 50-day SMA of $262.67, which acts as support, but below its 200-day SMA of $278.80, which serves as resistance. The RSI is neutral at 50.73, and the MACD is positive, indicating a balanced momentum."
  },
  {
   "question": "What is the insider sentiment for CME Group Inc. stock?",
   "answer": "Insider sentiment for CME Group Inc. is currently leaning towards selling. Insiders have sold $37.6 million worth of stock compared to purchases of $659.6 thousand, resulting in a 'Moderate Sell Signal' and a net seller position."
  },
  {
   "question": "How does CME Group Inc. compare to its sector averages?",
   "answer": "CME Group Inc.'s P/E ratio of 23.27 is higher than the sector median of 16.5. Its revenue growth of 0.8% is below the sector median of 11.7%. However, its ROE is not provided, and its debt-to-equity ratio is estimated at 0.8, which is in line with typical sector figures."
  },
  {
   "question": "What is CME Group Inc.'s dividend yield?",
   "answer": "CME Group Inc. offers a dividend yield of approximately 4.10%, with a dividend rate of $11.30."
  },
  {
   "question": "What is CME Group Inc.'s stock price prediction for 2030?",
   "answer": "Based on Monte Carlo simulations, CME Group Inc.'s stock price is projected to be $382.08 in 2030 under a base case scenario, with a downside projection of $203.80 and an upside projection of $716.31. These are statistical outcomes, not guarantees."
  }
 ],
 "related": {
  "peopleAlsoWatch": [
   {
    "ticker": "TROW",
    "name": "T. Rowe Price Group Inc. NASDAQ",
    "price": "$106.29",
    "change": "-1.17%",
    "url": "https://clearank.com/stock/t-rowe-price-trow/"
   },
   {
    "ticker": "ICE",
    "name": "Intercontinental Exchange, Inc. NYSE",
    "price": "$157.45",
    "change": "+1.05%",
    "url": "https://clearank.com/stock/intercontinental-exchange-ice/"
   },
   {
    "ticker": "MKTX",
    "name": "MarketAxess Holdings Inc. NASDAQ",
    "price": "$163.00",
    "change": "-0.06%",
    "url": "https://clearank.com/stock/mktx-stock-analysis/"
   },
   {
    "ticker": "WAL",
    "name": "Western Alliance Bancorporation NYSE",
    "price": "$79.29",
    "change": "+0.01%",
    "url": "https://clearank.com/stock/wal-stock-analysis/"
   },
   {
    "ticker": "HBAN",
    "name": "Huntington Bancshares Incorporated NASDAQ",
    "price": "$16.86",
    "change": "+0.78%",
    "url": "https://clearank.com/stock/hban-stock-analysis/"
   },
   {
    "ticker": "JPM",
    "name": "JPMorgan Chase & Co. NYSE",
    "price": "$356.23",
    "change": "+0.76%",
    "url": "https://clearank.com/stock/jpmorgan-chase-jpm/"
   },
   {
    "ticker": "C",
    "name": "Citigroup Inc. NYSE",
    "price": "$138.82",
    "change": "+0.23%",
    "url": "https://clearank.com/stock/citigroup-c/"
   },
   {
    "ticker": "PGR",
    "name": "The Progressive Corporation NYSE",
    "price": "$217.62",
    "change": "+0.66%",
    "url": "https://clearank.com/stock/progressive-pgr/"
   }
  ],
  "comparisons": [
   {
    "ticker": "LLY vs ABBV Comparison",
    "name": "",
    "url": "https://clearank.com/compare/lly-vs-abbv/"
   },
   {
    "ticker": "SCHD vs JEPI Comparison",
    "name": "",
    "url": "https://clearank.com/compare/schd-vs-jepi/"
   },
   {
    "ticker": "XLK vs QQQ Comparison",
    "name": "",
    "url": "https://clearank.com/compare/xlk-vs-qqq/"
   }
  ],
  "sectorHub": {
   "text": "Browse all Financial Services →",
   "url": "https://clearank.com/sector/financial-services/"
  },
  "Newly Tracked": [
   {
    "ticker": "SLVR",
    "text": "Sprott Silver Miners & Physical Silver ETF",
    "url": "https://clearank.com/etf/slvr-etf-analysis/"
   },
   {
    "ticker": "BRO",
    "text": "Brown & Brown Inc.",
    "url": "https://clearank.com/stock/bro-stock-analysis/"
   },
   {
    "ticker": "VRSK",
    "text": "Verisk Analytics, Inc.",
    "url": "https://clearank.com/stock/vrsk-stock-analysis/"
   },
   {
    "ticker": "DEO",
    "text": "Diageo plc Sponsored",
    "url": "https://clearank.com/stock/deo-stock-analysis/"
   },
   {
    "ticker": "KMB",
    "text": "Kimberly-Clark Corporation",
    "url": "https://clearank.com/stock/kmb-stock-analysis/"
   }
  ],
  "Top Movers (24h)": [
   {
    "ticker": "NTAP",
    "text": "↑ 8.54%",
    "url": "https://clearank.com/stock/netapp-ntap/"
   },
   {
    "ticker": "HPQ",
    "text": "↑ 8.40%",
    "url": "https://clearank.com/stock/hpq-stock-analysis/"
   },
   {
    "ticker": "LEU",
    "text": "↓ 8.18%",
    "url": "https://clearank.com/stock/centrus-energy-leu/"
   },
   {
    "ticker": "SYNA",
    "text": "↑ 8.09%",
    "url": "https://clearank.com/stock/synaptics-syna/"
   },
   {
    "ticker": "ASPI",
    "text": "↓ 7.80%",
    "url": "https://clearank.com/stock/aspi-asp-isotopes/"
   }
  ],
  "Also in Financial Services": [
   {
    "ticker": "COIN",
    "text": "Coinbase Global",
    "url": "https://clearank.com/stock/coinbase-coin/"
   },
   {
    "ticker": "ICE",
    "text": "Intercontinental",
    "url": "https://clearank.com/stock/intercontinental-exchange-ice/"
   },
   {
    "ticker": "MCO",
    "text": "Moody’s Corporation",
    "url": "https://clearank.com/stock/mco-stock-analysis/"
   },
   {
    "ticker": "NDAQ",
    "text": "Nasdaq, Inc.",
    "url": "https://clearank.com/stock/ndaq-stock-analysis/"
   },
   {
    "ticker": "SPGI",
    "text": "S&P Global Inc",
    "url": "https://clearank.com/stock/sp-global-spgi/"
   }
  ]
 },
 "schema": [
  {
   "@context": "https://schema.org",
   "@graph": [
    {
     "@type": "Place",
     "@id": "https://clearank.com/#place",
     "address": {
      "@type": "PostalAddress",
      "streetAddress": "Beni Berman 2",
      "addressLocality": "Netanya",
      "addressRegion": "Center",
      "postalCode": "4249330",
      "addressCountry": "IL"
     }
    },
    {
     "@type": "Organization",
     "@id": "https://clearank.com/#organization",
     "name": "CleaRank",
     "url": "https://clearank.com",
     "sameAs": [
      "https://twitter.com/CleaRank",
      "https://www.linkedin.com/company/clearank/",
      "https://www.youtube.com/@CleaRank"
     ],
     "email": "info@clearank.com",
     "address": {
      "@type": "PostalAddress",
      "streetAddress": "Beni Berman 2",
      "addressLocality": "Netanya",
      "addressRegion": "Center",
      "postalCode": "4249330",
      "addressCountry": "IL"
     },
     "logo": {
      "@type": "ImageObject",
      "@id": "https://clearank.com/#logo",
      "url": "https://clearank.com/wp-content/uploads/2025/02/CleaRank-Logo-e1738621466340.jpg",
      "contentUrl": "https://clearank.com/wp-content/uploads/2025/02/CleaRank-Logo-e1738621466340.jpg",
      "caption": "CleaRank",
      "inLanguage": "en-US",
      "width": "336",
      "height": "153"
     },
     "description": "The CleaRank vision is to bring clarity to the online trading industry and protect trader interests. We use our proprietary technology, expert analysis and verified trader insights, to deliver data driven broker evaluations you can trust. Our CLEAR™ Score is our foundation, a transparent, unbiased methodology that assesses brokers and firms based on the most critical factors including regulation, fees, platform reliability, and real user experiences. We are here to change an unfair system and unlike other review sites that are influenced by partnerships or subjective opinions, CleaRank is 100% independent–abiding by our rigorous CLEAR™ editorial code. We do not accept financial incentives from brokers, so what you see is what you get with no hidden agendas, just honest, actionable feedback. Clear data. Honest reviews. That's the CleaRank promise",
     "numberOfEmployees": {
      "@type": "QuantitativeValue",
      "value": "40"
     },
     "location": {
      "@id": "https://clearank.com/#place"
     }
    },
    {
     "@type": "WebSite",
     "@id": "https://clearank.com/#website",
     "url": "https://clearank.com",
     "name": "CleaRank",
     "publisher": {
      "@id": "https://clearank.com/#organization"
     },
     "inLanguage": "en-US"
    },
    {
     "@type": "ImageObject",
     "@id": "https://clearank.com/wp-content/uploads/2026/09/cme-analysis-2026-09.png",
     "url": "https://clearank.com/wp-content/uploads/2026/09/cme-analysis-2026-09.png",
     "width": "1280",
     "height": "720",
     "caption": "CME Group (CME) stock price analysis chart for September 2026",
     "inLanguage": "en-US"
    },
    {
     "@type": "BreadcrumbList",
     "@id": "https://clearank.com/stock/cme-stock-analysis/#breadcrumb",
     "itemListElement": [
      {
       "@type": "ListItem",
       "position": "1",
       "item": {
        "@id": "https://clearank.com",
        "name": "Home"
       }
      },
      {
       "@type": "ListItem",
       "position": "2",
       "item": {
        "@id": "https://clearank.com/stock/cme-stock-analysis/",
        "name": "CME Group Inc. (CME) Stock Analysis"
       }
      }
     ]
    },
    {
     "@type": "WebPage",
     "@id": "https://clearank.com/stock/cme-stock-analysis/#webpage",
     "url": "https://clearank.com/stock/cme-stock-analysis/",
     "name": "CME Group Inc. (CME) Stock Forecast & Price Target (2026)",
     "datePublished": "2026-09-01T09:27:07+00:00",
     "dateModified": "2026-09-12T03:45:58+00:00",
     "isPartOf": {
      "@id": "https://clearank.com/#website"
     },
     "primaryImageOfPage": {
      "@id": "https://clearank.com/wp-content/uploads/2026/09/cme-analysis-2026-09.png"
     },
     "inLanguage": "en-US",
     "breadcrumb": {
      "@id": "https://clearank.com/stock/cme-stock-analysis/#breadcrumb"
     }
    },
    {
     "@type": "Organization",
     "@id": "https://clearank.com/writer/clearank/",
     "name": "CleaRank",
     "description": "CleaRank's vision is to bring clarity to the online trading industry and protecting trader interests by delivering data-driven broker evaluations you can trust.",
     "url": "https://clearank.com/writer/clearank/",
     "image": {
      "@type": "ImageObject",
      "@id": "https://secure.gravatar.com/avatar/4900cf75f960a22a21f1c864e98abc4d5285fa159ea1025d0e8a9db5136e28ef?s=96&d=mm&r=g",
      "url": "https://secure.gravatar.com/avatar/4900cf75f960a22a21f1c864e98abc4d5285fa159ea1025d0e8a9db5136e28ef?s=96&d=mm&r=g",
      "caption": "CleaRank",
      "inLanguage": "en-US"
     },
     "sameAs": [
      "https://clearank.com/",
      "https://twitter.com/CleaRank",
      "https://www.linkedin.com/company/clearank/",
      "https://www.youtube.com/@CleaRank"
     ],
     "worksFor": {
      "@id": "https://clearank.com/#organization"
     },
     "logo": "https://clearank.com/wp-content/uploads/2025/02/CleaRank-Logo-e1738621466340.jpg"
    },
    {
     "@type": "Article",
     "headline": "CME Group Inc. (CME) Stock Forecast & Price Target (2026)",
     "datePublished": "2026-09-01T09:27:07+00:00",
     "dateModified": "2026-09-12T03:45:58+00:00",
     "author": {
      "@id": "https://clearank.com/writer/clearank/",
      "name": "CleaRank"
     },
     "publisher": {
      "@id": "https://clearank.com/#organization"
     },
     "description": "Is CME Group (CME) a Buy or Sell today? Get the AI trade setup, key support levels and derivatives volume outlook. Updated daily.",
     "name": "CME Group Inc. (CME) Stock Forecast & Price Target (2026)",
     "@id": "https://clearank.com/stock/cme-stock-analysis/#richSnippet",
     "isPartOf": {
      "@id": "https://clearank.com/stock/cme-stock-analysis/#webpage"
     },
     "image": {
      "@id": "https://clearank.com/wp-content/uploads/2026/09/cme-analysis-2026-09.png"
     },
     "inLanguage": "en-US",
     "mainEntityOfPage": {
      "@id": "https://clearank.com/stock/cme-stock-analysis/#webpage"
     }
    }
   ]
  },
  {
   "@context": "https://schema.org",
   "@type": "FinancialProduct",
   "name": "CME Group Inc. (CME)",
   "tickerSymbol": "CME",
   "url": "https://clearank.com/stock/cme-stock-analysis/",
   "description": "AI-powered financial analysis for CME Group Inc. (CME) including technical indicators, market metrics, valuation, and price targets - refreshed daily by CleaRank Financial AI.",
   "exchange": "NASDAQ",
   "offers": {
    "@type": "Offer",
    "price": 275.54001,
    "priceCurrency": "USD",
    "availability": "https://schema.org/InStock",
    "url": "https://clearank.com/stock/cme-stock-analysis/",
    "priceValidUntil": "2026-09-13"
   }
  },
  {
   "@context": "https://schema.org",
   "@type": "FAQPage",
   "mainEntity": [
    {
     "@type": "Question",
     "name": "Is CME Group Inc. stock a buy right now?",
     "acceptedAnswer": {
      "@type": "Answer",
      "text": "CME Group Inc. is currently rated as 'Hold' by Wall Street analysts, with a consensus score of 59 out of 100. The median analyst price target is $285.00, suggesting a limited upside of 3.4% from the current price of $275.54. While recent earnings showed a slight beat, moderate insider selling and a P/E ratio above the sector average warrant caution."
     }
    },
    {
     "@type": "Question",
     "name": "What is CME Group Inc.'s price target for September 2026?",
     "acceptedAnswer": {
      "@type": "Answer",
      "text": "The median analyst price target for CME Group Inc. is $285.00, indicating a 3.4% upside from the current trading price of $275.54. This target is based on the consensus of 16 Wall Street analysts."
     }
    },
    {
     "@type": "Question",
     "name": "How is CME Group Inc.'s revenue growth trending?",
     "acceptedAnswer": {
      "@type": "Answer",
      "text": "CME Group Inc. reported a year-over-year revenue growth of 0.8%. However, forward estimates are more optimistic, with current quarter revenue growth projected at +10.00% and current year growth at +8.00%."
     }
    },
    {
     "@type": "Question",
     "name": "What are the key technical levels for CME Group Inc. stock?",
     "acceptedAnswer": {
      "@type": "Answer",
      "text": "CME Group Inc. is trading above its 50-day SMA of $262.67, which acts as support, but below its 200-day SMA of $278.80, which serves as resistance. The RSI is neutral at 50.73, and the MACD is positive, indicating a balanced momentum."
     }
    },
    {
     "@type": "Question",
     "name": "What is the insider sentiment for CME Group Inc. stock?",
     "acceptedAnswer": {
      "@type": "Answer",
      "text": "Insider sentiment for CME Group Inc. is currently leaning towards selling. Insiders have sold $37.6 million worth of stock compared to purchases of $659.6 thousand, resulting in a 'Moderate Sell Signal' and a net seller position."
     }
    },
    {
     "@type": "Question",
     "name": "How does CME Group Inc. compare to its sector averages?",
     "acceptedAnswer": {
      "@type": "Answer",
      "text": "CME Group Inc.'s P/E ratio of 23.27 is higher than the sector median of 16.5. Its revenue growth of 0.8% is below the sector median of 11.7%. However, its ROE is not provided, and its debt-to-equity ratio is estimated at 0.8, which is in line with typical sector figures."
     }
    },
    {
     "@type": "Question",
     "name": "What is CME Group Inc.'s dividend yield?",
     "acceptedAnswer": {
      "@type": "Answer",
      "text": "CME Group Inc. offers a dividend yield of approximately 4.10%, with a dividend rate of $11.30."
     }
    },
    {
     "@type": "Question",
     "name": "What is CME Group Inc.'s stock price prediction for 2030?",
     "acceptedAnswer": {
      "@type": "Answer",
      "text": "Based on Monte Carlo simulations, CME Group Inc.'s stock price is projected to be $382.08 in 2030 under a base case scenario, with a downside projection of $203.80 and an upside projection of $716.31. These are statistical outcomes, not guarantees."
     }
    }
   ]
  }
 ]
}